Pitch Deck

Early Cancer Detection During Colonoscopy

Problem

Colorectal cancer is the second leading cause of cancer related death. Up to 28% of polyps are missed during colonoscopy procedures due to human factors, allowing polyps to develop into life-threatening late-stage cancers.

Solution

Ameretat is developing a real-time artificial intelligence, AI, system that analyzes colonoscopy video streams to highlight and characterize potential polyps. Our key differentiators:

  • High sensitivity, including flat lesions.
  • Real-time performance with minimal disruption.
  • Seamless integration into existing hospital infrastructure via cloud-based software, requiring minimal workflow changes.

Impact

Clinical Impact
Reduces polyp miss rate during colonoscopy, enabling earlier, more effective treatment.
Societal Relevance
A potential 10% improvement in polyp detection could save over 55,000 lives per year and reduce healthcare costs by more than $2.5 billion annually.

Market Access

Payers
By forming strategic partnerships with health tech providers, hospitals and screening centers will pay them directly, while we earn based on licensing agreements with partners.
Users
Gastroenterologists in hospitals and screening centers.
Differentiation
Unlike hardware solutions, our software-driven model avoids high upfront costs and enables a pay-per-procedure approach, making adoption easier and more scalable.

Traction

AI model
Developed over four years during a PhD to handle all image types and any device resolutions, performing exceptionally well even on very small datasets.
Clinical Data
Built on 14,000+ annotated polyp images from UMCG, in close collaboration with top clinicians.
Business Foundation
Over 1 year of entrepreneurial training via VentureLab, Life Cooperative, and continuing with NOM program, with multiple startup pitch competition wins.

Market

Global market Size of Colorectal cancer diagnostics expected to grow from $1.3B to $30.2B (2022-2032) at 8.8% CAGR.

AI in Healthcare market valued at $19.27B with 38.5% CAGR projected through (2022-2030).

Download Pitch Deck (PDF)